Inhalable ciprofloxacin/polymyxin B dry powders in respiratory infection therapy
The current study focused on the formulation, physicochemical characterization, and antibacterial susceptibility testing of inhalable spray dried powders containing ciprofloxacin (CIP) and polymyxin B sulfate (PMB). CIP nanosuspensions with an average particle diameter of 435.9 ± 9.3 nm were initial...
Saved in:
Main Authors: | Zhengqi Xu, Hriday Bera, Hengzhuang Wang, Junwei Wang, Dongmei Cun, Yu Feng, Mingshi Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2023-03-01
|
Series: | Acta Materia Medica |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2022-0050 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INNOVATION APPROACHES TO THE DEVELOPMENT OF DRY POWDER INHALERS
by: A. N. Vorobyev, et al.
Published: (2019-01-01) -
Pulmonary delivery of insulin by dry powder inhaler formulations
by: Mohsen Imenshahidi, et al.
Published: (2025-07-01) -
Effects of in vitro combination therapy with polymyxin B on delaying resistance in Klebsiella pneumoniae and insights into the mechanisms of polymyxin-induced resistance
by: Huanhuan Zhang, et al.
Published: (2025-06-01) -
Inhaled Polymyxin in Treatment of Elderly Patients with Severe Community-Acquired Klebsiella pneumoniae-Induced Pneumonia
by: V. I. Sakharov, et al.
Published: (2020-12-01) -
Development of Mannitol-Based Microparticles for Dry Powder Inhalers: Enhancing Pulmonary Delivery of NSAIDs
by: Petra Party, et al.
Published: (2025-06-01)